Literature DB >> 8847068

p53 protein expression in putative precursor lesions of epithelial ovarian cancer.

R Hutson1, J Ramsdale, M Wells.   

Abstract

p53 protein expression has been studied in epithelial inclusion cysts adjacent to and contralateral to serous carcinoma of the ovary and compared to epithelial inclusion cysts associated with borderline tumours and in normal ovaries. Atypia was found in epithelial inclusion cysts in eight of the thirteen advanced (stage III) serous ovarian carcinomas. Of these eight with atypical epithelial inclusion cysts, five showed immunoreactivity for p53. In the borderline tumours and normal ovaries no atypia in such cysts was found. p53 expression was also seen more frequently in surface epithelium associated with ovarian serous adenocarcinoma (ten of 13) than in normal ovaries (one of 13). We postulate that focal areas of atypia (ovarian intra-epithelial neoplasia) in epithelial inclusion cysts are the precursors of ovarian malignancy. In some cases, at least, p53 protein expression may precede overt cytological abnormalities.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8847068     DOI: 10.1111/j.1365-2559.1995.tb01528.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  18 in total

1.  Fallopian tube as main source for ovarian and pelvic (non-endometrial) serous carcinomas.

Authors:  Wenxin Zheng; Oluwole Fadare
Journal:  Int J Clin Exp Pathol       Date:  2012-03-25

2.  Early detection of ovarian cancer.

Authors:  Partha M Das; Robert C Bast
Journal:  Biomark Med       Date:  2008-06       Impact factor: 2.851

3.  Expression of a homeobox gene (SIX5) in borderline ovarian tumours.

Authors:  C Winchester; S Robertson; T MacLeod; K Johnson; M Thomas
Journal:  J Clin Pathol       Date:  2000-03       Impact factor: 3.411

Review 4.  The oviduct and ovarian cancer: causality, clinical implications, and "targeted prevention".

Authors:  Christopher P Crum; Frank D McKeon; Wa Xian
Journal:  Clin Obstet Gynecol       Date:  2012-03       Impact factor: 2.190

Review 5.  Serous tubal intraepithelial neoplasia: the concept and its application.

Authors:  Emily E K Meserve; Jan Brouwer; Christopher P Crum
Journal:  Mod Pathol       Date:  2017-01-20       Impact factor: 7.842

6.  A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations.

Authors:  Ann K Folkins; Elke A Jarboe; Aasia Saleemuddin; Yonghee Lee; Michael J Callahan; Ronny Drapkin; Judy E Garber; Michael G Muto; Shelley Tworoger; Christopher P Crum
Journal:  Gynecol Oncol       Date:  2008-03-14       Impact factor: 5.482

7.  Genetic analysis of the early natural history of epithelial ovarian carcinoma.

Authors:  Bhavana Pothuri; Mario M Leitao; Douglas A Levine; Agnès Viale; Adam B Olshen; Crispinita Arroyo; Faina Bogomolniy; Narciso Olvera; Oscar Lin; Robert A Soslow; Mark E Robson; Kenneth Offit; Richard R Barakat; Jeff Boyd
Journal:  PLoS One       Date:  2010-04-26       Impact factor: 3.240

Review 8.  Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer.

Authors:  Christopher P Crum; Ronny Drapkin; David Kindelberger; Fabiola Medeiros; Alexander Miron; Yonghee Lee
Journal:  Clin Med Res       Date:  2007-03

Review 9.  Intercepting pelvic cancer in the distal fallopian tube: theories and realities.

Authors:  Christopher P Crum
Journal:  Mol Oncol       Date:  2009-02-03       Impact factor: 6.603

10.  Ovarian cancer mouse models: a summary of current models and their limitations.

Authors:  Miranda Y Fong; Sham S Kakar
Journal:  J Ovarian Res       Date:  2009-09-28       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.